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Abstract The NDI1 gene encodes the internal rotenone-
insensitive NADH-quinone oxidoreductase localized in the inner
mitochondrial membranes of Saccharomyces cerevisiae. The T7
tag-fused mature NDI1 was overexpressed in Escherichia coli.
The overexpressed NDI1 was exclusively found in the membrane
fraction. The NDI1-overexpressed membranes showed signifi-
cantly increased activities of NADH oxidase and NADH-
ubiquinone-1 (UQ1) reductase when compared with the control
membranes. Flavone, which is a specific inhibitor of the S.
cerevisiae NDI1, inhibited almost completely NADH oxidase
and NADH-UQ1 reductase activities of NDI1-overexpressed
membranes but scarcely inhibited these activities of the control
membranes. In addition, the NADH oxidase activity of the
NDI1-overexpressed membranes was also inhibited by KCN as
well as the control membranes. These results indicate that the
overexpressed NDI1 worked as a member of the respiratory
chain in the host cells, even though E. coli membranes are
different from S. cerevisiae inner mitochondrial membranes in
terms of quinones and lipid composition.
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1. Introduction
Mammalian mitochondria are believed to contain only
complex I as the NADH-quinone (Q) oxidoreductase [1^4].
In contrast, mitochondria of Saccharomyces cerevisiae have
rotenone-insensitive NADH-Q oxidoreductases but lack com-
plex I [5]. In S. cerevisiae mitochondria, at least two distinct
rotenone-insensitive NADH-Q oxidoreductases are considered
to be present. One NADH-Q oxidoreductase is directed to the
cytoplasmic phase and the other is directed to the matrix
phase (designated internal rotenone-insensitive NADH-Q ox-
idoreductase) [6]. The internal rotenone-insensitive NADH-Q
oxidoreductases (NDI1) of mitochondria are reported to be
composed of a single subunit and to contain non-covalently
bound FAD as cofactors and no iron-sulfur clusters [2,4,6].
The functional overexpression of mitochondrial oxidative
phosphorylation enzyme complexes in bacteria is useful for
studies of structure and function of these enzyme complexes.
However, to date, such functional overexpression has not
been reported. Except for NDI1, other mitochondrial enzyme
complexes involved in oxidative phosphorylation are com-
posed of multiple di¡erent subunits and contain several di¡er-
ent cofactors. On the other hand, as described above, NDI1 is
composed of a single subunit and contains FAD only. There-
fore, it is of interest to attempt to natively overexpress the
NDI1 gene in Escherichia coli.
2. Materials and methods
A 5.5 kbp KpnI/PstI DNA fragment bearing the full-length NDI1
was excised from V 7056 (approximately 17 kbp S. cerevisiae DNA
inserted) and ligated into KpnI/PstI-cut cloning vector pTZ19U. The
resulting plasmid was designated pKP5.5. A 2.3 kbp SalI/EcoRV frag-
ment containing the full-length NDI1 was again excised from pKP5.5
and ligated into SalI/SmaI-cut cloning vector pTZ18U. The resulting
plasmid was designated pRVS2.3. Two oligonucleotide primers were
designed. One was to generate a NdeI recognition site at the precursor
protein initiation codon: 5P-GAAACTAAAAACCCATATGC-
TATCG-3P (the underlined bases were altered from S. cerevisiae
DNA, and italic bases indicate the NdeI site). The other was to con-
struct a BglII site at the mature protein initiation codon: 5P-
CTTCCACCAGATCTACAGGGGTGG-3P (the underlined base was
mutated from S. cerevisiae DNA and italic bases show the BglII site).
Site-speci¢c mutagenesis was carried out using the Bio-Rad in vitro
mutagenesis kit. The resulting plasmids were designated pRVS(NdeI)
and pRVS(BglII), respectively. pRVS(NdeI) was cut with NdeI and
BclI. The NdeI/BclI fragment was ligated into the NdeI/BamHI site in
pET11a and pET16b. As described previously [7], pET16b was de-
signed for expression of the His10 tag-fused protein. The resulting
expression plasmids were designated pET11a(NDI1) and pET16b(N-
DI1), respectively. pRVS(BglII) was digested with BglII and SacI. The
BglII/SacI fragment was ligated into the BamHI/SacI site in pET24a.
pET24a was designed for expression of the T7 tag-fused protein. The
resulting expression plasmid was designated pET24a(NDI1-m).
Competent E. coli strains BL21(DE3) and BL21(DE3)pLysS were
transformed with pET24a(NDI1-m), pET11a(NDI1), and pET16b(N-
DI1). Although e¡orts have been made to express the full length of
NDI1 using pET11a(NDI1) or pET16b(NDI1), the expression has not
been successful as yet. In contrast, T7 tag-fused mature NDI1 was
expressed in E. coli, using pET24a(NDI1-m). The optimum expression
procedure of pET24a(NDI1-m) was as follows. Colonies transformed
with pET24a(NDI1-m) lifted from the 2UYT agar plate containing 30
Wg/ml kanamycin were grown at 37‡C in 10 ml of 2UYT medium plus
kanamycin (30 Wg/ml) to the stationary phase. This suspension was
used to inoculate 500 ml of 2UYT medium (+30 Wg/ml kanamycin).
Cells were grown by stirring at 70^80 rpm at 37‡C to an absorbance
of approximately 0.6 at 600 nm. IPTG was then added (¢nal concen-
tration of 1 mM) and the cells were grown by slow gyration (70^80
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rpm) for 14 h at 37‡C. Competent strains E. coli BL21(DE3) harbor-
ing pET24a and lacking the plasmid were cultured by the same pro-
cedure.
Preparation of cytoplasmic and membrane fractions [8], raising
antibody to the NDI1 [8], puri¢cation of T7-tag fused NDI1 (the
protocol from Novagen), protein sequence determination [9], SDS-
polyacrylamide gel electrophoresis [10], amino acid composition [11],
DNA and amino acid sequence analyses [12], immunoblotting [8], and
assays of NADH oxidase, deamino-NADH oxidase, NADH-UQ1 re-
ductase and deamino-NADH-UQ1 reductase activities [13^15] were
done according to the references cited.
3. Results
We attempted to express the precursor and mature NDI1 in
E. coli using expression plasmids pET11a(NDI1), pET16b(N-
DI1) and pET24a(NDI1-m). Only expression of pET24a(N-
DI1-m) in E. coli strain BL21(DE3) was successful. The anti-
T7 tag antibody reacted with a single band of Mr = 57 000 in
SDS gels of the membrane fraction (but not in the soluble
fraction) of transformed BL21(DE3) cells (Fig. 1). The appar-
ent molecular mass of 57 kDa corresponded to the sum of
the masses of mature NDI1+T7 tag. Our expressed T7-tagged
mature NDI1 was extracted by 0.3% Triton X-100 from the E.
coli membranes and puri¢ed by anti-T7 antibody a⁄nity col-
umn (see Fig. 2). Higher Triton X-100 concentrations gave no
improvement in yield of the enzyme extraction. The amino
acid composition of the expressed T7-tagged mature NDI1
corresponded reasonably well to that deduced from DNA
encoding the T7-tagged mature NDI1 (data not shown). In
addition, in order to obtain sequence information on the T7-
tagged mature NDI1, the puri¢ed polypeptide was cleaved by
CNBr. One of the CNBr peptides (Mr = 26 000) had an N-
terminal sequence of KVIDPQ, which perfectly matched the
deduced primary structure at the carboxyl side of M43 of the
NDI1. These results indicate that the yeast mature NDI1 en-
zyme was correctly expressed in E. coli.
In the preparation step, the anti-T7 tag antibody a⁄nity
column turned yellow upon loading the Triton X-100 extract
from the membrane fraction, suggesting that the expressed
enzyme bears FAD. Therefore, the enzyme assays were car-
ried out with the NDI1-overexpressed membranes in order to
assess whether the expressed NDI1 is functionally active in E.
coli membranes. The NDI1 membranes exhibited approxi-
mately 3.5 and 12.5 times, respectively, higher NADH oxidase
and NADH-UQ1 reductase activities than the membranes iso-
lated from E. coli harboring pET24a (data not shown). The
deamino-NADH oxidase activities were extremely low in all
three membranes. Regarding the activity ratio of deamino-
NADH oxidase to NADH oxidase the NDI1-overexpressed
membranes showed a signi¢cantly higher value than the other
two control membranes. In the case of the membrane-bound
NDH-2 of E. coli, the ratio was estimated to be 0.007. A
similar ratio was obtained from membrane-bound NDH-2
in Bacillus subtilis. On the other hand, the ratio was 0.08 using
S. cerevisiae SMP. This value is similar to the ratio of the
NDI1-overexpressed membranes. DCCD treatment (at 520
WM for 1 h at 20‡C) did not a¡ect the NADH-UQ1 reductase
activity of the NDI1-overexpressed membranes, whereas the
activities of the control membranes were inhibited by 50% by
treatment with DCCD. As reported previously [14], DCCD
scarcely a¡ects NADH-UQ1 reductase activity of the S. cer-
evisiae SMP. On the other hand, DCCD treatment inhibits
NADH-UQ1 and NADH-K3Fe(CN)6 reductase activities of
the NDH-2-overexpressed E. coli (IY-91) membranes by ap-
proximately 50% (T. Yagi, unpublished results). In addition,
the ratio of NADH-UQ1 reductase to NADH oxidase in
NDI1-expressed membranes was high (approximately 6). Sim-
ilar trends were observed in S. cerevisiae SMP but not in E.
coli membranes (approximately 1.5). Taken together, these
results suggest that the T7 tag-fused mature NDI1 was func-
tionally overexpressed in E. coli membranes.
In order to con¢rm the functional expression of the mature
NDI1, the e¡ect of £avone, a speci¢c inhibitor for S. cerevi-
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Fig. 1. Western blotting analyses of the expressed mature NDI1 of
S. cerevisiae using anti T7 antibody. A: Membrane fraction. B:
Soluble fraction. 2.5 Wg of protein were applied on each lane. Lane
1, BL21(DE3) transformed with pET24a; lane 2, BL21(DE3) trans-
formed with pET24a(NDI1-m); lane 3, BL21(DE3)/pLysS trans-
formed with pET24a; lane 4, BL21(DE3)/pLysS transformed with
pET24a(NDI1-m); lane 5, 116 kDa L-galactosidase expressed in
BL21(DE3); lane 6, 37 kDa control protein with T7 tag sequence.
Fig. 2. Puri¢cation of the expressed T7 tag-fused mature NDI1
from E. coli. A: SDS-polyacrylamide gel. B: Immunoblot using al-
kaline phosphatase-conjugated monoclonal antibody to the T7 tag.
Lane (M), molecular markers used were 97, 64, 45 and 31 kDa;
lane 1, cell lysate of E. coli harboring pET24a(NDI1-m); lane 2,
membrane fraction; lane 3, extract with 0.3% Triton X-100 from
membrane fraction; lane 4, fraction was not absorbed by anti-T7
tag antibody a⁄nity column; lane 5, puri¢ed T7 tag-fused mature
NDI1.
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siae NDI1 [6], was investigated on the NADH oxidase of the
NDI1-expressed membranes. As shown in Fig. 3, NADH ox-
idase of the NDI1-expressed membranes is sensitive to £avone
as opposed to the activities of the control membranes. The I50
value of £avone in NDI1 membranes is approximately 100
WM, which is consistent with the I50 value (95 WM) of the
membrane-bound and isolated yeast NDI1 [6]. A similar I50
value (90 WM) was found for the NADH-UQ1 reductase ac-
tivity of the NDI1-overexpressed membranes.
The respiratory chain in aerobically grown E. coli is com-
posed of NADH-Q oxidoreductases (NDH-1 [FMN and sev-
eral iron-sulfur clusters] and NDH-2 [FAD]), succinate-Q ox-
idoreductase (FAD and FeS clusters), quinones (ubiquinone-
8, menaquinone-8, and demethylmenaquinone-8), and two
quinol oxidases [16,17]. On the other hand, the respiratory
chain in S. cerevisiae mitochondria contains NADH-Q oxi-
doreductases (NDI1 [FAD] and external NDH), succinate-Q
oxidoreductase, ubiquinone-6, complex III (hemes bH, bL and
c1 and [2Fe-2S]), and cytochrome oxidase (3Cu and hemes a
and a3). The inhibitory e¡ect of £avone in Fig. 3 suggests that
the NADH oxidase of the NDI1-overexpressed E. coli mem-
branes is almost entirely catalyzed by the expressed yeast
NDI1. The results with deamino-NADH and DCCD support
this notion. If the expressed NDI1 plays a role as a member of
the host cell respiratory chain, the NADH oxidase catalyzed
by the NDI1 should be inhibited by speci¢c inhibitors for
other respiratory chain enzyme complexes in host cells in a
similar manner to the control membranes. KCN is recognized
to be a speci¢c inhibitor of the quinol oxidase enzyme com-
plexes in the E. coli respiratory chain [16]. We investigated the
e¡ect of KCN on the NADH oxidase activities of NDI1-over-
expressed membranes and control membranes in order to ver-
ify this issue. As shown in Fig. 4, the inhibitory e¡ects of
KCN on the NADH oxidase of various membranes are sim-
ilar to each other. These results indicate that the expressed
NDI1 in E. coli membranes functions as a member of the
respiratory chain in host cells.
The kinetics of NADH oxidase of the three membranes was
reasonably ¢tted by a simple Michaelis-Menten equation in a
range of NADH concentration from 8 WM to 150 WM (data
not shown). As seen in Table 1, the Km value (8.3 WM) for
NADH in the NDI1-overexpressed membranes was approxi-
mately three times lower than those in the control membranes
(+pET24a and 3pET24a) and was also four times lower than
the Km value (31 WM) for NADH for the NDI1 isolated from
yeast SMP [6]. Concerning V/Km, which is equivalent to the
¢rst-order rate constant for NADH binding to the NADH
dehydrogenase, the NDI1-overexpressed membranes exhibit
a value one order of magnitude higher than the two control
membranes. These results suggest that the NDI1 expressed in
E. coli oxidizes NADH more e⁄ciently than its authentic
NDH-2.
4. Discussion
Although inner yeast mitochondrial membranes are signi¢-
cantly di¡erent from E. coli cytoplasmic membranes in terms
of quinones and lipid composition [6,17], S. cerevisiae NDI1
can be functionally overexpressed in E. coli and acts as a
member of the respiratory chain in host cells. Therefore, the
functional expression of mitochondrial multiple subunit en-
zyme complexes involved in oxidative phosphorylation in E.
coli may be possible although several problems should be
overcome.
Mammalian mitochondria oxidize NADH only through
complex I. As far as we know at present, complex I has the
most intricate structure among the membrane-bound enzyme
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Fig. 4. E¡ect of KCN on NADH oxidase activities of membranes
from NDI1-overexpressed BL21(DE3) (a), BL21(DE3) transformed
with pET24a (b), and BL21(DE3) (O). For the assays, the mem-
branes were added to the reaction mixture to a ¢nal concentration
of 5 Wg of protein/ml.
Fig. 3. E¡ect of £avone on NADH oxidase activities of membranes
from NDI1-overexpressed BL21(DE3) (a), BL21(DE3) transformed
with pET24a (b), and BL21(DE3) (O). The assays were performed
at membrane concentrations of 5 Wg of protein/ml at 30‡C.
Table 1
Comparison of kinetic parameters of NADH oxidase among NDI1-
overexpressed and control membranes with and without pET24aa
Membranes
NDI1 +pET24a 3pET24a
Vb 8.8 2 3.2
KNADHm (WM) 8.3 23 25
V=KNADHm 1.06 0.09 0.13
aAssay conditions are described in Section 2.
bMicromol of NADH oxidized per min per mg of protein.
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complexes (at least 43 unlike subunits) [1^3]. Recently, it has
been reported that defects of complex I are involved in many
human mitochondrial diseases [18]. Various chemotherapies
have been reported to be ine¡ective at the present time [19].
Dysfunction of complex I in human mitochondria causes
three problems: (a) decrease in ATP synthesis, (b) increase
in the ratio of NADH to NAD, (c) production of superoxide
anion. The impairment of proton pumping by one of the three
proton translocation sites does not appear to be as severe a
health hazard as the inability of the mitochondria to oxidize
NADH. Therefore, a possible approach for coping with com-
plex I defects is to introduce into mammalian mitochondria a
NDI1-type enzyme. As described above, NDI1 is a versatile
enzyme. Therefore, it may be conceivable that NDI1 is an
excellent candidate for this purpose at the present time.
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